Action Observation Treatment for Upper Limb Rehabilitation in Patients With Stroke: Protocol for a Multicenter Randomized Controlled Trial.
EEG
action observation treatment
electroencephalography
qEEG
quantitative electroencephalography
stroke rehabilitation
upper limb kinematics
Journal
JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504
Informations de publication
Date de publication:
20 Apr 2023
20 Apr 2023
Historique:
received:
07
09
2022
accepted:
10
03
2023
revised:
09
03
2023
medline:
20
4
2023
pubmed:
20
4
2023
entrez:
20
04
2023
Statut:
epublish
Résumé
In the last few years, new noninvasive strategies have emerged as rehabilitative treatments for patients with stroke. Action observation treatment (AOT) is a rehabilitation approach based on the properties of the mirror neuron system with a positive impact on modifying cortical activation patterns and improving the upper limb kinematics. AOT involves the dynamic process of observing purposeful actions with the intention of imitating and then practicing those actions. In recent years, several clinical studies suggested the effectiveness of AOT in patients with stroke to improve motor recovery and autonomy in activities of daily living. However, a deeper knowledge of the behavior of the sensorimotor cortex during AOT seems to be essential. The aim of this clinical trial, conducted in 2 neurorehabilitation centers and in patients' homes, is to investigate the effectiveness of AOT in patients with stroke, confirming the translational power of a tailored treatment. Particular emphasis will be placed on the predictive value of neurophysiological biomarkers. In addition, the feasibility and impact of a home-based AOT program will be investigated. A 3-arm, assessor-blinded, randomized controlled trial will be performed by enrolling patients with stroke in the chronic stage. A total of 60 participants will be randomly allocated to receive 15 sessions of AOT with different protocols (AOT at the hospital, AOT at home, and sham AOT), 3 sessions per week. The primary outcome will be assessed using the Fugl-Meyer Assessment-Upper Extremity scores. Secondary outcomes will be clinical, biomechanical, and neurophysiological assessment. The study protocol is part of a project (project code GR-2016-02361678) approved and funded by the Italian Ministry of Health. The study began with the recruitment phase in January 2022, and enrollment was expected to end in October 2022. Recruitment is now closed (December 2022). The results of this study are expected to be published in spring 2023. Upon completion of the analyses, we will examine the preliminary effectiveness of the intervention and neurophysiological outcomes. This study will be used to evaluate the effectiveness of 2 different AOT scenarios (ie, AOT at the hospital and AOT at home) in patients with chronic stroke and to assess the predictive value of neurophysiological biomarkers. Specifically, we will attempt to induce the functional modification of the cortical components by exploiting the features of the mirror neuron system, demonstrating relevant clinical, kinematic, and neurophysiological changes after AOT. With our study, we also want to provide, for the first time in Italy, the AOT home-based program while assessing its feasibility and impact. ClinicalTrials.gov NCT04047134; https://clinicaltrials.gov/ct2/show/NCT04047134. DERR1-10.2196/42094.
Sections du résumé
BACKGROUND
BACKGROUND
In the last few years, new noninvasive strategies have emerged as rehabilitative treatments for patients with stroke. Action observation treatment (AOT) is a rehabilitation approach based on the properties of the mirror neuron system with a positive impact on modifying cortical activation patterns and improving the upper limb kinematics. AOT involves the dynamic process of observing purposeful actions with the intention of imitating and then practicing those actions. In recent years, several clinical studies suggested the effectiveness of AOT in patients with stroke to improve motor recovery and autonomy in activities of daily living. However, a deeper knowledge of the behavior of the sensorimotor cortex during AOT seems to be essential.
OBJECTIVE
OBJECTIVE
The aim of this clinical trial, conducted in 2 neurorehabilitation centers and in patients' homes, is to investigate the effectiveness of AOT in patients with stroke, confirming the translational power of a tailored treatment. Particular emphasis will be placed on the predictive value of neurophysiological biomarkers. In addition, the feasibility and impact of a home-based AOT program will be investigated.
METHODS
METHODS
A 3-arm, assessor-blinded, randomized controlled trial will be performed by enrolling patients with stroke in the chronic stage. A total of 60 participants will be randomly allocated to receive 15 sessions of AOT with different protocols (AOT at the hospital, AOT at home, and sham AOT), 3 sessions per week. The primary outcome will be assessed using the Fugl-Meyer Assessment-Upper Extremity scores. Secondary outcomes will be clinical, biomechanical, and neurophysiological assessment.
RESULTS
RESULTS
The study protocol is part of a project (project code GR-2016-02361678) approved and funded by the Italian Ministry of Health. The study began with the recruitment phase in January 2022, and enrollment was expected to end in October 2022. Recruitment is now closed (December 2022). The results of this study are expected to be published in spring 2023. Upon completion of the analyses, we will examine the preliminary effectiveness of the intervention and neurophysiological outcomes.
CONCLUSIONS
CONCLUSIONS
This study will be used to evaluate the effectiveness of 2 different AOT scenarios (ie, AOT at the hospital and AOT at home) in patients with chronic stroke and to assess the predictive value of neurophysiological biomarkers. Specifically, we will attempt to induce the functional modification of the cortical components by exploiting the features of the mirror neuron system, demonstrating relevant clinical, kinematic, and neurophysiological changes after AOT. With our study, we also want to provide, for the first time in Italy, the AOT home-based program while assessing its feasibility and impact.
TRIAL REGISTRATION
BACKGROUND
ClinicalTrials.gov NCT04047134; https://clinicaltrials.gov/ct2/show/NCT04047134.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)
UNASSIGNED
DERR1-10.2196/42094.
Identifiants
pubmed: 37079364
pii: v12i1e42094
doi: 10.2196/42094
pmc: PMC10160932
doi:
Banques de données
ClinicalTrials.gov
['NCT04047134']
Types de publication
Journal Article
Langues
eng
Pagination
e42094Informations de copyright
©Peppino Tropea, Francesco Infarinato, Irma Sterpi, Marco Ottaviani, Paola Antoniotti, Paola Romano, Michela Picardi, Michela Goffredo, Riccardo Re, Sanaz Pournajaf, Agnese Seregni, Antonio Caronni, Marco Franceschini, Massimo Corbo. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 20.04.2023.
Références
Arch Physiother. 2015 Dec 2;5:14
pubmed: 29340183
Phys Med Rehabil Clin N Am. 2010 Feb;21(1):157-78
pubmed: 19951784
Biomed Res Int. 2016;2016:7051340
pubmed: 27057546
Dev Med Child Neurol. 2012 Sep;54(9):822-8
pubmed: 22765352
Science. 2005 Apr 29;308(5722):662-7
pubmed: 15860620
Neurorehabil Neural Repair. 2011 Mar-Apr;25(3):223-33
pubmed: 21051765
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Top Stroke Rehabil. 2016 Oct;23(5):318-25
pubmed: 27077994
Neurorehabil Neural Repair. 2008 Jan-Feb;22(1):50-63
pubmed: 17626223
Biomed Res Int. 2014;2014:251041
pubmed: 24822187
Neurorehabil Neural Repair. 2015 Jul;29(6):509-16
pubmed: 25416737
Neurorehabil Neural Repair. 2022 Sep;36(9):574-586
pubmed: 36000699
Eur J Phys Rehabil Med. 2012 Jun;48(2):313-8
pubmed: 22522432
Cochrane Database Syst Rev. 2014 Nov 12;(11):CD010820
pubmed: 25387001
Arch Rehabil Res Clin Transl. 2021 Jan 27;3(1):100106
pubmed: 33778479
Stroke. 2008 Jun;39(6):1814-20
pubmed: 18403746
J Neurol Neurosurg Psychiatry. 1987 Jun;50(6):714-9
pubmed: 3612152
Phys Ther. 1987 Feb;67(2):206-7
pubmed: 3809245
Cochrane Database Syst Rev. 2018 Oct 31;10:CD011887
pubmed: 30380586
J Neuroeng Rehabil. 2013 Oct 05;10:103
pubmed: 24093623
Behav Brain Res. 2011 Nov 20;225(1):201-8
pubmed: 21802449
J Electromyogr Kinesiol. 2000 Oct;10(5):361-74
pubmed: 11018445
J Clin Epidemiol. 1989;42(8):703-9
pubmed: 2760661
IEEE Trans Neural Syst Rehabil Eng. 2018 Apr;26(4):882-893
pubmed: 29641393
Neurosci Res. 2018 Aug;133:7-14
pubmed: 29031830
Neurorehabil Neural Repair. 2012 Jun;26(5):456-62
pubmed: 22235059
J Neurosci. 2005 Oct 12;25(41):9339-46
pubmed: 16221842
PLoS One. 2015 Dec 07;10(12):e0144256
pubmed: 26641241
J Neurosci. 2002 Sep 15;22(18):8297-304
pubmed: 12223584
Neurosci Biobehav Rev. 2020 Nov;118:828-845
pubmed: 32966815
J Med Internet Res. 2019 Oct 1;21(10):e12805
pubmed: 31573902
Conscious Cogn. 2013 Sep;22(3):1095-104
pubmed: 23545395
Medicine (Baltimore). 2017 Oct;96(42):e8080
pubmed: 29049194
Arch Gerontol Geriatr. 2008 Jul-Aug;47(1):79-91
pubmed: 17868935
Annu Rev Neurosci. 2004;27:169-92
pubmed: 15217330
Stroke. 2005 Nov;36(11):2493-6
pubmed: 16224078
J Neurophysiol. 2003 Nov;90(5):3270-82
pubmed: 14615432
BMJ. 2013 Jan 08;346:e7586
pubmed: 23303884
J Neuroeng Rehabil. 2014 Mar 04;11:22
pubmed: 24594139
Exp Neurol. 1997 Jul;146(1):159-70
pubmed: 9225749
Physiol Rev. 2014 Apr;94(2):655-706
pubmed: 24692357
Neural Plast. 2018 Apr 24;2018:2321045
pubmed: 29853839
Stroke. 2013 Aug;44(8):2247-53
pubmed: 23743974
Philos Trans R Soc Lond B Biol Sci. 2014 Apr 28;369(1644):20130185
pubmed: 24778380
J Phys Ther Sci. 2016 Jun;28(6):1748-52
pubmed: 27390408
Cochrane Database Syst Rev. 2017 Nov 20;11:CD008349
pubmed: 29156493
Scand J Rehabil Med. 1975;7(1):13-31
pubmed: 1135616
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Cereb Cortex. 2010 Jun;20(6):1372-85
pubmed: 19805419
J Exp Psychol Gen. 2012 Feb;141(1):2-18
pubmed: 21823805
Anat Embryol (Berl). 2005 Dec;210(5-6):419-21
pubmed: 16222545
Clin Rehabil. 2019 Aug;33(8):1277-1285
pubmed: 30977387
Scand J Rehabil Med Suppl. 1980;7:85-93
pubmed: 6932734
Restor Neurol Neurosci. 2015;34(1):45-54
pubmed: 26518670
PLoS One. 2019 Aug 30;14(8):e0221166
pubmed: 31469840
Am J Occup Ther. 1985 Jun;39(6):386-91
pubmed: 3160243
Neuroimage. 2006 Jan 15;29(2):677-84
pubmed: 16125417
Brain. 1996 Apr;119 ( Pt 2):593-609
pubmed: 8800951
Eur J Phys Rehabil Med. 2010 Dec;46(4):517-23
pubmed: 20414184
Neuroimage. 2007;36 Suppl 2:T164-73
pubmed: 17499164
Nat Rev Neurosci. 2010 Apr;11(4):264-74
pubmed: 20216547
Neurorehabil Neural Repair. 2014 Nov-Dec;28(9):874-84
pubmed: 24642381
Neuroimage. 2014 Feb 15;87:127-37
pubmed: 24140938